Fosmanogepix treatment for coccidioidomycosis under an expanded access program

By afschroeder • April 22, 2026

Cohen SH, Allyn P, Chow FC, Rathe J, Nanayakkara DD, Hutfles G, Vijayan T, Smith EA, Saling CF, Ilges D, Schlamm HT, Thompson GR 3rd. Fosmanogepix treatment for coccidioidomycosis under an expanded access program. Clin Infect Dis. 2026 Apr 21:ciag271. doi: 10.1093/cid/ciag271. Epub ahead of print. PMID: 42015519.

Tags: antifungal, Coccidioidomycosis, expanded access program, fosmanogepix, Infectious Diseases, Publications

Determinants of PrEP Delivery Platform Choice in Adolescents and Young People: The Fast-PrEP Project in Cape Town, South Africa

Rousseau E, Bondarchuk C, Lebelo K, Matsebula L, Bennin F, Macdonald P, Pike C, Vanto O, Mathole N, Fynn L, Davey DJ, Coakley C, Wallace[...]

Proteomic Immune Signatures of Severe HIV-Associated Tuberculosis in Sub-Saharan Africa: A Prospective, Multicenter Analysis From Uganda

Ross JE, Tomoiaga AS, Owor N, Lu X, Shinyale J, Kiyingi T, Asasira I, Eliku PJ, Nsubuga JB, Nsereko C, Nayiga I, Kyebambe S, Ochar[...]

“Someone could have told me”: a qualitative study on experiences with hysterectomy decision-making and regret in Mysore, India

Herbst de Cortina S, Karanam R, Pramathesh R, Begum F, Jaykrishna P, Srinivas V, Hariprasad R, Madhivanan P, Adsul P, Somaiya D. "Someone could have[...]